Elanco Announces Agreement to Acquire Lohmann Animal Health; Lowers FY 2014 Earnings Guidance to $2.72-2.80 on a Non-GAAP Basis

Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY ), today announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately-held company headquartered in Cuxhaven, Germany. Lohmann Animal Health is a global leader in the supply of poultry vaccines and also markets a